NASDAQ:XSPA
Delisted
XpresSpa Group Inc. Stock News
$0.450
+0.0512 (+12.84%)
At Close: Jan 27, 2023
XpresSpa Pivots Back From Covid Testing With A More Balanced Retail Vision
05:18pm, Thursday, 29'th Sep 2022
XpresSpa's share price remains dangerously low at around 75 cents, but the revival of the spa business offers hope.
XpresSpa Group, Inc. (XSPA) CEO Scott Milford on Q2 2022 Results - Earnings Call Transcript
07:00pm, Monday, 15'th Aug 2022
XpresSpa Group, Inc. (NASDAQ:XSPA ) Q2 2022 Earnings Conference Call August 15, 2022 4:30 PM ET Company Participants Omar Haynes - Interim CFO Scott Milford - CEO Joseph Calabrese - IR Conference Call
XpresSpa Group, Inc. (XSPA) Reports Q2 Loss, Tops Revenue Estimates
06:48pm, Monday, 15'th Aug 2022
XpresSpa Group, Inc. (XSPA) delivered earnings and revenue surprises of 20% and 1.24%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
XpresSpa Group to Announce Second Quarter 2022 Financial Results on Monday, August 15
04:30pm, Wednesday, 10'th Aug 2022
Webcast and Conference Call Scheduled for 4:30 PM ET Webcast and Conference Call Scheduled for 4:30 PM ET
XpresSpa Group, Inc. (XSPA) Reports Q1 Loss, Tops Revenue Estimates
07:33pm, Monday, 16'th May 2022
XpresSpa Group, Inc. (XSPA) delivered earnings and revenue surprises of 33.33% and 23.83%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
XpresSpa Group, Inc.'s (XSPA) CEO Scott Milford on Q1 2022 Results - Earnings Call Transcript
06:04pm, Monday, 16'th May 2022
XpresSpa Group, Inc. (NASDAQ:XSPA ) Q1 2022 Earnings Conference Call May 16, 2022 4:30 PM ET Company Participants James Berry - Chief Financial Officer Scott Milford - Chief Executive Officer Raphael
XpresSpa Group to Announce First Quarter 2022 Financial Results on May 16
04:30pm, Thursday, 12'th May 2022
Webcast and Conference Call Scheduled for 4:30 PM ET Webcast and Conference Call Scheduled for 4:30 PM ET
Insiders Are Dumping These Penny Stocks, Look Out Below Or Buy The Dip?
02:57pm, Tuesday, 26'th Apr 2022
Time to sell these penny stocks? The post Insiders Are Dumping These Penny Stocks, Look Out Below Or Buy The Dip?
XpresSpa Group, Inc. (XSPA) CEO Scott Milford on Q4 2021 Results - Earnings Call Transcript
12:33am, Wednesday, 16'th Mar 2022 Seeking AlphaXpresSpa GAAP EPS of $0.03 misses by $0.03, revenue of $29.36M beats by $2.22M
08:49pm, Tuesday, 15'th Mar 2022 Seeking Alpha
XpresSpa press release (XSPA): Q4 GAAP EPS of $0.03 misses by $0.03.Revenue of $29.36M (+9075.0% Y/Y) beats by $2.22M.Shares +8.49%.Strongest Financial Results in Company History…
XpresSpa Group, Inc. (XSPA) CEO Scott Milford on Q4 2021 Results - Earnings Call Transcript
08:33pm, Tuesday, 15'th Mar 2022
XpresSpa Group, Inc. (XSPA) CEO Scott Milford on Q4 2021 Results - Earnings Call Transcript
XpresSpa Group to Announce Fourth Quarter and Full Year 2021 Financial Results on March 15
01:00pm, Monday, 14'th Mar 2022
Webcast and Conference Call Scheduled for 4:30 PM ET Webcast and Conference Call Scheduled for 4:30 PM ET
Blustering Stock: XpresSpa Group, Inc. (NASDAQ:XSPA), Tellurian Inc. (AMEX:TELL)
09:41am, Monday, 14'th Mar 2022 Stock Equity
XpresSpa Group, Inc. (NASDAQ:XSPA) with the stream of -6.54% also noticed, India Tellurian Inc. (AMEX:TELL) encountered a rapid change of 1.76% in the last hour of Friday’s trading session. XpresSpa … The post Blustering Stock: XpresSpa Group, Inc. (NASDAQ:XSPA), Tellurian Inc. (AMEX:TELL) appeared first on Stocks Equity .
XpresSpa Extends Partnership With CDC For Biosurveillance At US Airports
07:41pm, Monday, 31'st Jan 2022 Benzinga
XpresSpa Group Inc (NASDAQ: XSPA ) has extended its initial $2 million airport-based biosurveillance program with the Centers for Disease Control and Prevention (CDC) through its subsidiary XpresCheck. The extension brings the total Full story available on Benzinga.com
XpresSpa Extends Partnership With CDC For Biosurveillance At US Airports
02:41pm, Monday, 31'st Jan 2022
XpresSpa Group Inc (NASDAQ: XSPA) has extended its initial $2 million airport-based biosurveillance program with the Centers for Disease Control and Prevention (CDC) through its subsidiary XpresCh
